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In 1988 Julian Tudor Hart prescribed ‘A new 
kind of doctor’, calling for data-intensive, 
community-responsive primary care.1 He 
argued for a realignment of primary care 
with the needs of populations rather than 
individuals; and for greater emphasis on 
prevention.1 These principles are largely 
ingrained in modern UK general practice: 
clinical commissioning groups (CCGs), the 
Quality and Outcomes Framework (QOF), 
and audit all require primary care to consider 
information about practice populations; and 
disease prevention is routine practice. The 
new era of ‘big data’ is likely to escalate 
further such approaches but may also 
change the conversation of primary care 
between patients, practitioners, and the 
public.
Systematic collection, collation, and 
analysis of data were core to Hart’s manifesto. 
Today’s primary care has more advanced 
tools at its disposal. Electronic health 
records are the foundations on which we 
build alerts and reminders to guide decisions 
at the point of care. Electronic templates 
help capture key data on conditions and 
care pathways. These data can be extracted 
across IT systems for research (for example, 
the Clinical Practice Research Datalink 
[CPRD], The Health Improvement Network 
[THIN], QResearch, and ResearchOne in the 
UK; the NIVEL Primary Care Database in the 
Netherlands; or SIDIAP in Spain), and across 
populations to support service development 
(for example, audit, www.openprescribing.
net) and incentivise activity (for example, QOF 
in the UK, the Primary Health Organization 
[PHO] Performance Programme in New 
Zealand, or Practice Incentives Program 
[PIP] in Australia).
Traditionally, large-scale data extracts of 
NHS care records have been seen as the 
way to realise the more systematic primary 
care that Hart envisioned. Extracted records 
may be combined with other data at a 
national level such as hospital admissions 
and discharges from claims data, or 
official government statistics such as death 
registrations. More detailed information at 
regional level, however, is more complex, 
especially across important boundaries 
such as between health and social care. 
This is unsurprising considering each local 
health system may host vast quantities of 
databases that record and support care.2 
Also, the traditional paradigm of core 
minimum datasets is being challenged 
because multiple aspects of our daily lives 
are now linked by common technologies 
such as smartphones and smartwatches — 
generating health-relevant data invisibly, like 
patterns of movement, and interactively, like 
apps for symptom monitoring, medication 
reminders, and access to primary care 
records. The potential to link primary care 
with the digital by-products of everyday life 
holds the promise of better prevention, self-
care, and monitoring. But the community 
and population focus of primary care could 
be weakened through inequalities: the better 
off and the healthy may well find it easier to 
engage with the digital age.
TWO NEW KINDS OF DATA
We see two main types of new ‘big data’ 
impacting on primary care in future: active 
and passive. Active in situations where the 
user is consciously producing health-related 
data, for example, by interacting with apps, 
and passive where they are not, for example, 
accelerometer data from smartphones or 
smartwatches.
There is a plethora of apps already 
available, though relatively few that have 
been validated to provide credible data. The 
UK NHS is currently building a library of 
‘approved’ apps, although the number of 
apps being developed is likely to outstrip the 
capacity for regulation and accreditation in 
the UK or other countries. Consequently, 
some apps, which are being used for both 
clinical research and care, have developed 
their own validation paths. In the UK, 
ClinTouch (www.clintouch.com) uses 
validated questions and methods to support 
patients with psychosis to monitor their 
symptoms, and alert their clinical team if a 
problem is suspected; Cloudy with a Chance 
of Pain (www.cloudywithachanceofpain.com) 
collects symptom data from patients with 
arthritis directly from their smartphone to 
investigate the association with weather. 
PatientView (www.patientview.org) is a 
website that enables patients with kidney 
disease, inflammatory bowel disease, or 
diabetes to view their medical records, 
and add symptoms and patient-reported 
outcomes. Internationally, Singapore’s 
Ministry of Health provides a range of web-
based and smartphone apps for patients 
(www.healthhub.sg), and in primary care, 
Apple Health enables patients to access 
their electronic medical record and input 
physiological measurements (compatible 
with various different vendors). Apps can 
also provide evidence-based treatments 
recommended by clinical guidelines, such as 
cognitive behavioural therapy (CBT), which 
provide data on usage and adherence.3
By contrast, passive data may be collected 
from a variety of sources. Smart electricity 
meters collect data that might be used to 
predict whether older patients have fallen or 
have a change in daily living pattern indicating 
they have run into problems.4 Studies 
from the US demonstrate that analysis 
of social media may identify symptoms 
related to disease outbreaks5 or mental 
health problems.6 Location technologies 
in mobile phones can track patients with 
dementia and alert health services if they 
are in danger. Smartwatches can detect 
seizures or characterise tremors.7 Dosette 
boxes linked to the internet can provide 
useful insights into medication adherence. 
Everyday life is becoming routinely digital.
The primary care record could form a 
vital bridge between the active and passive 
data sources above — creating new insights 
for individual patient care, population care, 
and research. For example, analysing a 
patient’s home blood pressure readings may 
help identify white-coat hypertension and 
avoid unnecessary increases in medication; 
assessing a patient with depression’s 
adherence to smartphone-based CBT may 
identify alternative treatments; and knowing 
that a patient has not opened their dosette box 
of hypoglycaemic medications could explain 
their uncontrolled diabetes. Understanding 
changes in population patterns of physical 
activity could bridge primary care and public 
health approaches to health improvement. 
Trends in social media content and web 
searches for symptoms signal disease 
outbreaks and could help with immediate 
service planning. For research, more deeply 
connected data across multiple, better-
characterised populations can transform 
(clinical) epidemiology and feed evidence 
deserts such as understanding the needs of 
patients with multiple conditions.
THREE BIG CHALLENGES
Big data, however, bring big challenges 
including: governance, evaluation, and 
unintended consequences. The governance 
regarding ‘active’ data sources is relatively 
straightforward, as users can give consent 
and see what the data are being used for, 
and by whom. If these data are used for 
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unintended or unclear purposes, users can 
be made aware and objections subsequently 
raised. ‘Passive’ data are more problematic 
as users may not be aware they are 
generating health-related information. 
Dame Fiona Caldicott’s latest report asks 
us to reconsider the nature of consent and 
patient feedback on data uses.8 Possibilities 
include dynamic consent, whereby patients 
control consent continuously and receive 
information about the uses of their data.9 
These challenges are not unique to medicine 
though. There is a general move towards 
citizens controlling their own data, and being 
able to see how their data are used across the 
spectrum of public and private services. The 
UK Department of Health’s new Connected 
Health Cities initiative reuses wider civic 
digital governance for better health data 
analytics (www.connectedhealthcities.org).
The second challenge is that new data 
sources require rigorous evaluation before 
introduction. For example, to employ smart 
electric meter data requires evidence that 
has not yet been generated.4 Telecare 
research may or may not be relevant.10 
These are complex interventions where 
implementation and evaluation are 
difficult,11 but to ignore available and 
potentially valuable data that may improve 
care is arguably negligent. On the other 
hand, digital interventions have come 
unstuck where they are rolled out without 
due evaluation and understanding, such 
as the Summary Care Record in the UK’s 
out-of-hours care.12 A major challenge for 
vendors of clinical information systems is to 
avoid data corruption or security breaches 
through linked apps, therefore very few apps 
are likely to be approved for connection.
Third is the digital cousin of ‘primum non 
nocere’ (first do no harm), and the potential 
unintended consequences of introducing 
new ‘big’ data sources. An immediate 
risk from the explosion in connected 
health technologies is to exacerbate the 
‘digital divide’ where the under-served are 
under-sampled — a modern equivalent of 
Hart’s inverse care law. Older and poorer 
people may become more isolated as 
healthcare depends on consumption of 
domestic technologies. This would also 
impact on population health management 
and research, where data samples 
are not representative of the population 
being served. A greater emphasis on 
ubiquitous over ‘nice to have’ consumer 
technologies is one way to mitigate this 
risk. Workload inflation is another potential 
problem — a blizzard of poorly or partially 
analysed data will further stretch primary 
care resources, which are already under 
considerable pressure.13 For example, 
daily blood pressure recordings sent via 
apps are not useful in every patient but still 
require processing, risking overwhelming 
clinicians. Systems should be developed 
that only convey essential information, 
and any additional workload should be 
adequately resourced. Furthermore, a 
lack of preparedness for more clinical data 
may precipitate over-reaction, for example, 
unnecessary hospitalisation when a patient 
with COPD’s oxygen saturations sent via 
telecare benignly dip. While in the research 
setting, more linked data may tempt 
researchers to ‘overfit’ and report specious 
associations.
CONCLUSION
In a more connected world, there are new 
opportunities to link data to primary care 
records that go beyond the traditional 
paradigm of ‘big’ health data. The UK is 
ideally placed to reveal important new 
understanding about the interactions of 
biology, behaviours, and environments — 
and primary care is at the heart of that nexus. 
Like Hart, we see no dividing line between 
research and care quality improvement, and 
therefore call for an honest conversation 
with patients and citizens about the value of 
the data they generate. This should build on 
the strong traditions of using primary care 
data for these purposes, but should also 
evolve to connect with community-based 
data sources that can provide a bigger 
picture of health and care. However, these 
new opportunities also pose big challenges, 
and careful evaluation and negation of 
unintended risks are vital.
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